References
- CJ Partsch, and WG Sippell. (2001). Pathogenesis and epidemiology of precocious puberty. Effects of exogenous oestrogens. Hum Reprod Update 7:292–302.
- G Teilmann, A Juul, NE Skakkebaek, and J Toppari. (2002). Putative effects of endocrine disrupters on pubertal development in the human. Best Pract Res Clin Endocrinol Metab 16:105–121.
- H Vierhapper, and P Nowotny. (1999). Gynaecomastia and raised oestradiol concentrations. Lancet 353:640.
- EI Felner, and PC White. (2000). Prepubertal gynecomastia: Indirect exposure to estrogen cream. Pediatrics 105:E55.
- D Thieme, P Anielski, J Grosse, H Sachs, and RK Mueller. (2003). Identification of anabolic steroids in serum, urine, sweat and hair. Comparison of metabolic patterns. Anal Chim Acta 483:299–306.
- GM Fara, G Del Corvo, S Bernuzzi, A Bigatello, C Di Pietro, S Scaglioni, and G Chiumello. (1979). Epidemic of breast enlargement in an Italian school. Lancet 2:295–297.
- A Loizzo, GL Gatti, A Macrì, G Moretti, E Ortolani, and S Palazzesi. Italian baby food containing diethylstilboestrol: Three years later. Lancet 1984 1:1014–1015.
- P Kintz. (2003). Testing for anabolic steroids in hair: a review. Leg Med 5:S29–S33.
- KA Walters, KR Brain, DM Green, VJ James, AC Watkinson, and RH Sands. (1998). Comparison of the transdermal delivery of estradiol from two gel formulations. Maturitas 29:189–195.
- LS Abrams, D Skee, J Natarajan, and FA Wong. (2002). Pharmacokinetic overview of Ortho Evra/Evra. Fertil Steril 77:S3–S12.
- G Russo, MP Guarneri, MP Garancini, K Perackis, S Riboni, A Taveggia, PL Paesano, F Ferrara, S Di Candia, and G Chiumello. (2003). Epidemic of breast enlargement in a school population: A twenty-year follow up. Ital J Pediatr 29:57–60.
- PW Harvey, and P Darbre. (2004). Endocrine disrupters and human health: Could oestrogenic chemicals in body care cosmetics adversely affect breast cancer incidence in women?. J Appl Toxicol 24:167–176.